Improvement of islet transplantation by the fusion of islet cells with functional blood vessels
Open Access
- 2 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 13 (1), e12616
- https://doi.org/10.15252/emmm.202012616
Abstract
Pancreatic islet transplantation still represents a promising therapeutic strategy for curative treatment of type 1 diabetes mellitus. However, a limited number of organ donors and insufficient vascularization with islet engraftment failure restrict the successful transfer of this approach into clinical practice. To overcome these problems, we herein introduce a novel strategy for the generation of prevascularized islet organoids by the fusion of pancreatic islet cells with functional native microvessels. These insulin‐secreting organoids exhibit a significantly higher angiogenic activity compared to freshly isolated islets, cultured islets, and non‐prevascularized islet organoids. This is caused by paracrine signaling between the β‐cells and the microvessels, mediated by insulin binding to its corresponding receptor on endothelial cells. In vivo, the prevascularized islet organoids are rapidly blood‐perfused after transplantation by the interconnection of their autochthonous microvasculature with surrounding blood vessels. As a consequence, a lower number of islet grafts are required to restore normoglycemia in diabetic mice. Thus, prevascularized islet organoids may be used to improve the success rates of clinical islet transplantation.Keywords
This publication has 72 references indexed in Scilit:
- Animal Models of Diabetes Mellitus for Islet TransplantationExperimental Diabetes Research, 2012
- Advances and Challenges in Islet Transplantation: Islet Procurement Rates and Lessons Learned from Suboptimal Islet TransplantationJournal of Transplantation, 2011
- Islet Graft Survival and Function: Concomitant Culture and Transplantation With Vascular Endothelial Cells in Diabetic RatsTransplantation, 2011
- Disruption of Hepatocyte Growth Factor/c-Met Signaling Enhances Pancreatic β-Cell Death and Accelerates the Onset of DiabetesDiabetes, 2011
- The hypoxia response pathway and β‐cell functionDiabetes, Obesity and Metabolism, 2010
- Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cellsStem Cell Research & Therapy, 2010
- Revascularization of Transplanted IsletsDiabetes, 2008
- Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7Proceedings of the National Academy of Sciences of the United States of America, 2008
- Edmonton's islet success has indeed been replicated elsewhereThe Lancet, 2003
- Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts.JCI Insight, 1992